Sales from Jan Aushadhi Kendras are expected to surpass the Rs 2,000-crore mark in the 2024-25 fiscal year, according to Ravi Dadhich, CEO of the Pharmaceuticals and Medical Devices Bureau of India (PMBI). Currently, 15,000 outlets are operational across the country under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) scheme.
About the Author
